Antibiotics and Infectious Respiratory Diseases

Respiratory infectious diseases (rIDs) remain among the most significant causes of morbidity and mortality worldwide, and, in the era of COVID-19, they have come into major focus in the scientific world and global health approaches. They can have a viral, bacterial, parasitic or opportunistic origin; however, indiscriminate use of antibiotics in their treatment has led to the development of antimicrobial resistance. Effective management of respiratory infectious diseases to reduce their burden and to avoid overuse of antibiotics has become a great therapeutic and public health challenge. This Special Issue of ‘Antibiotics’ focuses on various aspects of medical and clinical use of antimicrobials in infectious respiratory diseases in real-life settings. Nine articles (including a review article) are included, each focusing on a different issue in an essential field of applied research, furthering the scientific knowledge on this important topic.